By increasing the depth, using unique molecular barcode, and employing special design of bioinformatics software, different NGS assays have been published with different sensitivities in measuring FLT3–ITD for AML MRD49,53–55. The gene discussed is FLT3; the disease is acute myeloid leukemia.